Evidence map›Paper›PMID 41280889›Full record

ArticleFrontiers in immunology2025

Long-term outcome of bone marrow transplantation in NIK deficiency: non-redundant role of non-canonical NF-κB signaling in thymic reconstitution and secondary lymphoid organ development.

Sevgi Köstel Bal, Şule Haskoloğlu, Bernhard Ransmayr, Selin Sevinç, Candan İslamoğlu, Kübra Baskın, Nazlı Deveci, Berna Savaş, Suat Fitoz, Alphan Küpesiz and 4 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sevgi Köstel BalDepartment of Pediatric Allergy and Immunology, Gülhane Research and Training Hospital, University of Health Sciences, Ankara, Türkiye.
Şule HaskoloğluDepartment of Pediatric Immunology and Allergy, Ankara University School of Medicine, Ankara, Türkiye.
Bernhard RansmayrSt Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Selin SevinçDepartment of Pediatric Immunology and Allergy, Ankara University School of Medicine, Ankara, Türkiye.
Candan İslamoğluDepartment of Pediatric Immunology and Allergy, Ankara University School of Medicine, Ankara, Türkiye.
Kübra BaskınDepartment of Pediatric Allergy and Immunology, Gazi University School of Medicine, Ankara, Türkiye.
Nazlı DeveciEtlik City Hospital Department of Pediatric Allergy and Immunology, University of Health Sciences, Ankara, Türkiye.
Berna SavaşDepartment of Pathology, Ankara University School of Medicine, Ankara, Türkiye.
Suat FitozDivision of Radiology, Ankara University School of Medicine, Ankara, Türkiye.
Alphan KüpesizDepartment of Pediatric Hematology, Akdeniz University Faculty of Medicine, Antalya, Türkiye.
Tanıl KendirliDepartment of Pediatric Intensive Care, Ankara University School of Medicine, Ankara, Türkiye.
Kaan BoztugSt Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Figen DoğuDepartment of Pediatric Immunology and Allergy, Ankara University School of Medicine, Ankara, Türkiye.
Kamile Aydan İkincioğullarıDepartment of Pediatric Immunology and Allergy, Ankara University School of Medicine, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Biallelic mutations in Method: We report long-term outcomes of two patients with genetically confirmed NIK deficiency who underwent HSCT. Results: Both patients achieved full donor chimerism and early T-cell reconstitution with normalized CD3 Discussion: These results highlight the importance of long-term immunologic monitoring, including assessments for immune dysregulation and anti-cytokine autoantibodies. Future therapies should consider adjunct strategies such as thymic regeneration or targeted immune modulation to address the underlying architectural defects in this disorder.

Indexed as

Bone Marrow TransplantationLymphoid TissueNF-kappa BProtein Serine-Threonine KinasesThymus GlandHematopoietic Stem Cell TransplantationHumansNF-kappaB-Inducing KinaseSignal TransductionTreatment OutcomeNF-kappa BNF-kappaB-Inducing KinaseProtein Serine-Threonine Kinasescentral tolerancecombined immunodeficiencyhematopoietic stem cell transplantationNIK deficiencynon-canonical NFKB signaling

Identifiers

PMID41280889
PMCPMC12634528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.